1. Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer. Issue 9 (18th June 2020) Authors: von der Lippe Gythfeldt, Hedda; Lien, Tonje; Tekpli, Xavier; Silwal‐Pandit, Laxmi; Borgen, Elin; Garred, Øystein; Skjerven, Helle; Schlichting, Ellen; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Kristensen, Vessela; Børresen‐Dale, Anne‐Lise; Lingjærde, Ole Christian; Engebraaten, Olav Journal: International journal of cancer Issue: Volume 147:Issue 9(2020) Page Start: 2515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗